Comprehensive Segmental Revision System(SRS)

Comprehensive Segmental Revision System(SRS) is an FDA 510(k)-cleared medical device (K223631) manufactured by Biomet Orthopedics. This device is classified under the Orthopedic specialty. FDA Device Class II (Special Controls) — moderate risk, requires 510(k) clearance. FDA clearance granted on July 11, 2023. Regulation: 8.